Page 7 - Heart Transplant Guidelines
P. 7

Heart Function Service: Heart Transplant Guidelines

                    Premedication: .................................................................................................................................... 64

                    Dosing: ................................................................................................................................................ 64
                    IV Infusion: .......................................................................................................................................... 64

                    Anaphylaxis: ........................................................................................................................................ 64

                    Infectious Disease Prophylaxis: ........................................................................................................... 65
                    Contraindications: ............................................................................................................................... 65

                    Adverse Reactions: .............................................................................................................................. 65
                  Protocol for Administration of Basiliximab (Simulect®) ......................................................................... 66

                    Dose: ................................................................................................................................................... 66
                    Administration: ................................................................................................................................... 66

                    Side Effects: ......................................................................................................................................... 66
                  Protocol for Administration of Rituximab (Rituxan®) ............................................................................. 67

                    Premedication:  1 hr prior to infusion................................................................................................. 67
                    Dose: ................................................................................................................................................... 67

                    Infusion: .............................................................................................................................................. 67

                    Anaphylaxis: ........................................................................................................................................ 67
                    Drug Interactions: ............................................................................................................................... 67

                    Side Effects: ......................................................................................................................................... 68
                  Protocol for Administration of Intravenous Immunoglobulin (IVIG) ...................................................... 70

                  Protocols for the Administration of Bortezomib (Velcade®) .................................................................. 76
                  Protocol for Administration of Belatacept (Nulojix®) ............................................................................. 79

                  Protocol for Administration of Alemtuzumab (Campath®) .................................................................... 80

                  Protocols for the Administration of Eculizumab (Soliris®) ...................................................................... 81
                  Protocol for Administration of Valganciclovir (Valcyte®) ....................................................................... 83

               Normal Blood Pressure Values.................................................................................................................... 85





















               Updated November 13, 2018                                                                    7
   2   3   4   5   6   7   8   9   10   11   12